Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.2091
-0.0081 (-3.73%)
At close: Feb 12, 2026, 4:00 PM EST
0.2197
+0.0106 (5.07%)
After-hours: Feb 12, 2026, 7:27 PM EST
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $1.55 million as of February 12, 2026. Its market cap has decreased by -82.56% in one year.
Market Cap
1.55M
Enterprise Value
-1.29M
1-Year Change
-82.56%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $1.55M, a decrease of -99.25%. That is a compound annual growth rate of -74.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.61M | -37.19% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CDT Equity | 2.53M |
| Lyra Therapeutics | 2.43M |
| Cardio Diagnostics Holdings | 2.41M |
| Ernexa Therapeutics | 2.37M |
| Bone Biologics | 2.33M |
| CNS Pharmaceuticals | 2.25M |
| Azitra | 2.20M |
| PMGC Holdings | 2.02M |